1. News & Events
  2. Newsroom
  3. FDA clears first ‘rapid diagnostic’ hepatitis C RNA test for point-of-care settings

FDA clears first ‘rapid diagnostic’ hepatitis C RNA test for point-of-care settings

Share:

EmailFacebookLinkedInXWhatsAppShare
NIBIB in the News
June 28, 2024

The FDA granted marketing authorization for Cepheid’s Xpert HCV test and GeneXpert Xpress System, the first rapid test for hepatitis C virus intended for use in point-of-care settings. Source: Helio

Explore More

Heath Topics

Research Topics

PROGRAM AREAS

Inside NIBIB